Archives of rehabilitation research and clinical translation · 2020
Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pucks-Faes Elke, Dobesberger Judith, Halbmayer Lucas-Michael, Hitzenberger Gabriel, Matzak Heinrich, Saltuari Leopold
Аннотация
OBJECTIVE: To assess the complications of dual placement of an intrathecal baclofen (ITB) pump and a ventriculoperitoneal shunt (VPS) in people with severe brain injury.
DESIGN: Case series.
SETTING: Referral center, ambulatory, and hospitalized care.
PARTICIPANTS: Referred sample (N=9) composed of 5 men and 4 women with severe brain injuries (5 traumatic brain injuries, 3 subarachnoid hemorrhages, 1 intracerebral hemorrhage) and a mean disease duration of 6±4.5 years (range, 0.5-11.4y).
INTERVENTION: Both systems (ie, an ITB device and a VPS system) were implanted in all participants.
MAIN OUTCOME MEASURES: We assessed the number and type of complications that occurred after implantation of the second system, as well as subsequent interventions.
RESULTS: The ITB delivery system was implanted after the VPS system in 5 patients (ITB group), and the VPS system was the second implanted system in 4 groups (VPS group). Seven complications occurred in 7 patients after implantation of the second system, 4 in the ITB group and 3 in the VPS group. Three of the complications were drug-related, 2 were procedure-related, and 2 were device-related. The complication occurred within 4 days after implantation of the second system in 6 patients.
CONCLUSIONS: Complications are frequent in patients who undergo implantation of both an ITB delivery device and a VPS system. Drug-related complications were more common. Complications occurred more often when an ITB device was implanted as the second system. The critical period is the first 4 days.
DESIGN: Case series.
SETTING: Referral center, ambulatory, and hospitalized care.
PARTICIPANTS: Referred sample (N=9) composed of 5 men and 4 women with severe brain injuries (5 traumatic brain injuries, 3 subarachnoid hemorrhages, 1 intracerebral hemorrhage) and a mean disease duration of 6±4.5 years (range, 0.5-11.4y).
INTERVENTION: Both systems (ie, an ITB device and a VPS system) were implanted in all participants.
MAIN OUTCOME MEASURES: We assessed the number and type of complications that occurred after implantation of the second system, as well as subsequent interventions.
RESULTS: The ITB delivery system was implanted after the VPS system in 5 patients (ITB group), and the VPS system was the second implanted system in 4 groups (VPS group). Seven complications occurred in 7 patients after implantation of the second system, 4 in the ITB group and 3 in the VPS group. Three of the complications were drug-related, 2 were procedure-related, and 2 were device-related. The complication occurred within 4 days after implantation of the second system in 6 patients.
CONCLUSIONS: Complications are frequent in patients who undergo implantation of both an ITB delivery device and a VPS system. Drug-related complications were more common. Complications occurred more often when an ITB device was implanted as the second system. The critical period is the first 4 days.